Share Name Share Symbol Market Type Share ISIN Share Description
Nmc Health Plc LSE:NMC London Ordinary Share GB00B7FC0762 ORD 10P
  Price Change % Change Share Price Shares Traded Last Trade
  -57.00 -4.06% 1,347.50 4,605,047 16:35:25
Bid Price Offer Price High Price Low Price Open Price
1,341.00 1,343.50 1,413.00 1,285.50 1,375.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 2,057.25 256.85 119.60 11.3 2,812
Last Trade Time Trade Type Trade Size Trade Price Currency
18:28:27 O 11,692 1,347.50 GBX

Nmc Health (NMC) Latest News (1)

More Nmc Health News
Nmc Health Takeover Rumours

Nmc Health (NMC) Discussions and Chat

Nmc Health Forums and Chat

Date Time Title Posts
26/1/202007:15NMC Health4,977
21/1/202011:08NMC Health new44
20/12/201913:25SP-
26/4/201916:25One of the best stocks-
03/9/201219:50North Midland Construction - strong buy trading on a p/e of 4x for this year2

Add a New Thread

Nmc Health (NMC) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Nmc Health trades in real-time

Nmc Health (NMC) Top Chat Posts

DateSubject
26/1/2020
08:20
Nmc Health Daily Update: Nmc Health Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker NMC. The last closing price for Nmc Health was 1,404.50p.
Nmc Health Plc has a 4 week average price of 1,200p and a 12 week average price of 1,192p.
The 1 year high share price is 3,059p while the 1 year low share price is currently 1,192p.
There are currently 208,714,264 shares in issue and the average daily traded volume is 1,339,184 shares. The market capitalisation of Nmc Health Plc is £2,812,424,707.40.
13/1/2020
10:56
mister md: FINANCIAL MAIL ON SUNDAY PUBLISHED: 22:13 GMT, 11 January 2020 | UPDATED: 14:02 GMT, 12 January 2020 Belaguered private healthcare giant NMC Health is preparing to take legal action after a short-selling attack on the FTSE 100 firm wiped £2.6billion off its value, The Mail on Sunday can reveal. Shares in NMC Health – a Middle Eastern hospitals group listed in London – halved last month after American short-seller Muddy Waters published a damning report that raised red flags over NMC Health's accounting practices, claiming its finances pointed to possible 'fraudulent asset values and the theft of company assets'. A source close to the company revealed it has engaged two major law firms to advise on filing a possible lawsuit to repair its reputation. The source said: 'NMC Health is considering all potential legal remedies, both civil and criminal.' The legal claim will focus on actions taken by third parties to 'mislead the market and manipulate the share price', according to a statement to the stock exchange. Muddy Waters, run by the notorious bear raider Carson Block, and a group of hedge funds based in the US, Switzerland and London, cashed in from the share price fall because they were 'shorting' the shares. Funds that have built up short positions in NMC include AQR Capital, PSquared, Gladstone Capital Management and Portsea. Short-selling is a tactic that allows hedge funds to borrow shares under contract, returning them to the original owner when the price falls and pocketing the difference. The NMC insider said the crash triggered by Muddy Waters' report on December 17 has created a 'material loss' for NMC's pension fund backers and institutional investors, which include BlackRock and Legal & General. NMC Health operates private hospitals and fertility clinics in 19 countries including the UK. Its co-chairman is Indian billionaire Bavaguthu Raghuram Shetty, 77, who founded the Abu Dhabi-based group and is a major shareholder. Two of NMC's other major shareholders, Emirati billionaires Saeed and Khalifa Bin Butti, last week sold NMC shares worth $490million (£375million) at a discount to cover loans owed to Credit Suisse and Deutsche Bank, causing a further fall in the shares. NMC has said it will confirm its cash balances as part of an independent review of its finances. But Muddy Waters said similar reviews are usually 'exercises in whitewashing that provide little to no transparency or accountability'. It pointed out that other firms it has attacked through critical reports, such as commodity trader Noble Group and Chinese forestry group Sino-Forest, were both exonerated by their purportedly independent reviews, only to collapse later. Dr Shetty said in a statement that he 'fully supports the independent investigation and process in order to clarify matters'. NMC declined to comment on the litigation.
11/1/2020
20:01
sentimentrules: Muddy Waters have made statements on 4 dates: 17/12 20/12 23/12 02/01 06/01 NMC countered on: 18/12 19/12 20/12 23/12 06/01 An even ding dong and both last did it on same date. ....................... NMC ERROR re: London, 20 December 2019: NMC Health plc (LSE: NMC) notes the publication of the article published in Financial Times on 20 December 2019 titled “NMC held talks to raise €200m in off-balance sheet debt to fund growth”. The Company confirms that this article is based on false information and finds speculation regarding a transaction that didn’t occur to be completely unproductive. NMC regularly meets investor and potential lender groups and takes its obligations seriously. As a listed company NMC is held to high standards in relation to reporting and disclosures and engages with a variety of top tier professional firms to ensure adherence to such standards. . NMC considers this to be the latest in a long line of malicious attempts by certain parties to influence commentary around the Company in a negative fashion to damage its credibility and negatively impact its share price via methods which are at times nefarious, unethical and illegal. In addition to publishing a comprehensive rebuttal to the recently issued report by Muddy Waters (hxxps://cfcdn.nmc.ae/Uploads/InvestorRelations/nmc-health-plc-response-to-recent-report-19-dec-2019-adb66d0b4047-4d4d-94f2-fb9a84d2d301.pdf), the Company has approached the Financial Conduct Authority with evidence to show that a number of hedge funds have been acting in concert and systematic fashion to undermine shareholder value in NMC via acts including, but not limited to: • Colluding with sell-side research, including increasing their short positions ahead of publication of negative research reports; • Paying for negative third-party research to be published by an “independent” research house; • Spreading unsubstantiated allegations, often based on falsehood, to undermine the credibility of management. NMC is also considering other legal options available to address these issues. ................ Thats the FT and friends out the window to be helpful. This release just about alienated media, to city. And most likely the regulator who works for the city looooool
08/1/2020
11:07
stdyeddy: If you're a shareholder here, you must be wondering; what's coming next? It's one thing to have an openly speculative Muddy Waters attack, but quite another to have the company's owners smash the share price. I'm wondering about a few things. If MW hadn't launched it's 'expose' (most of it now heavily refuted and at least disputed) on NMC, would the two sellers have been able to sell their stock at maybe £18? In other words, has Carson Block cost these two magnates a couple of hundred million pounds? If I were him, I'd cross India and the Middle-East off my holiday destination list. The sellers; it is just two men, right? There's about a dozen names in the notice. I wonder what their friends call them. Presumably you just pick one depending on how well you know them. I thought there might be a strong recovery in the share price but it seems to have run out of steam at this point. I'm guessing at two factors; buyers of the loaned stock turning a quick profit and existing shareholders running out of patience with NMC as an investment. Do people here think it could go lower than £12? I have no position at the moment and am just kicking myself for not being short yesterday. But from here, where does it go? £10 or £14? The other factor is the NMC share buyback. Now we can make an educated guess as to why it was halted; presumably the banks preferred that the share price was not being artificially inflated before agreeing the purchase. Are the brakes off now? Will a man with a tea towel on his head and 12 names in his passport tell a broker to resume buying NMC stock? Or will they wait for the overhang to clear? Any thoughts welcome.
20/12/2019
09:29
spob: NMC held talks to raise €200m in off-balance sheet debt to fund growth Https://www.ft.com/content/c3469f08-2231-11ea-b8a1-584213ee7b2b Healthcare group under pressure from short-sellers over scale of borrowing Cynthia O’Murchu and Robert Smith in London 4 hours ago Financial Times NMC Health has held talks to raise hundreds of millions of dollars of off-balance sheet debt to fund new hospitals, despite the FTSE 100 healthcare provider having faced increased scrutiny from short-sellers over the scale of its borrowing. The Middle Eastern healthcare group, which is controlled by a small group of United Arab Emirates-based billionaires, was previously one of the star performers on the London stock market with its shares starting the year up more than 1,000 per cent from its 2012 initial public offering. But the company’s shares dropped as much as 42 per cent on Tuesday after short-seller Muddy Waters raised “serious doubts” about NMC’s finances in a 34-page report, taking more than £2.3bn off its market value. The Abu Dhabi-based company has faced mounting questions from analysts, investors and short-sellers this year about its apparent use of off-balance sheet financing techniques, which do not count to its official debt levels. It is one of the most heavily shorted stocks in the FTSE 100, with about a quarter of its free float out on loan for use by hedge funds. While NMC has made public statements reassuring investors about its limited use of such structures, the company has this year sought to raise a €200m loan through a complicated chain of special-purpose vehicles, according to people familiar with the matter. Draft deal documents seen by the Financial Times and dating from the spring and summer show that NMC planned to raise the loan through a Dubai entity, to fund the construction of hospitals as it seeks to continue its aggressive expansion in the Middle East. NMC operates facilities in 19 countries and said it served about 4m patients in the six months to June. This Dubai project company would borrow the €200m from a financing vehicle in Luxembourg, backed by shares in two of the company’s existing hospitals in the UAE. Estates SA, a Luxembourg investment firm listed in the documents as helping set up the special-purpose vehicle in the grand duchy, confirmed to the Financial Times that they had “analysed this project”. “In the end, the project has not been implemented with us,” the spokesperson added. While the deal documents clearly state that NMC Health plc would guarantee the loan, two people with direct knowledge of the deal said the complicated structure was aimed at allowing the company to exclude the facility from its corporate debt figures. As the deal has not yet been completed, however, it is not possible to know how it would have been disclosed. NMC Health declined to comment. The group, whose share price has not recovered since Muddy Waters’ report, initially hit back calling it “unfounded, baseless and misleading” and subsequently published a detailed rebuttal on Wednesday evening. Muddy Waters homed in on NMC’s use of reverse factoring or supply-chain finance, which is a form of borrowing against supplier payments that accountants do not class as debt. The financing technique is controversial due to its role in the collapse of UK outsourcer Carillion and Spanish energy company Abengoa. The California-based hedge fund described a statement made by NMC last month about its use of supply-chain finance as “an attempt to mislead” investors. NMC, in a detailed rebuttal to Muddy Waters’ allegations, said that it “simply provided an undertaking in the form of a guarantee to settle the accepted trade payables against each invoice”. While not mentioned in Muddy Waters’ report, much of NMC’s supply-chain finance has been arranged by Blackstar Capital, a London-based firm that specialises in helping companies raise working capital finance. Blackstar is also behind the efforts to raise the €200m loan to fund new hospitals. In contrast to the supply-chain finance facilities, which are commonly used if controversial, several people familiar with the proposed deal described it as highly unconventional. “This is not how you expect a FTSE 100 company to finance itself,” said one. Blackstar declined to comment. South Korean asset manager Hyundai Asset Management was in talks to invest the full amount, according to several people familiar with the negotiations. One person directly involved in the deal said that the investor’s reservations about some aspects of the complicated structure had delayed the financing. “Hyundai AM is not related to the NMC Health investment case,” said a spokesperson for the Korean group, without providing further clarification.
18/12/2019
07:40
tsmith2: Response to Share Price MovementNMC Health plc ("NMC" or the "Company") notes the publication of the report from Muddy Waters on 17 December 2019 and the resultant share price reaction.NMC understands its regulatory disclosure obligations and has nothing to add to disclosures already made. It has already responded to many of the allegations made in the report over the past 12 months, which can be found on the Company website, see https://nmc.ae/investor-relations.NMC will review the assertions, insinuations and accusations made in the report, which appear principally unfounded, baseless and misleading, containing many errors of fact, and will respond in detail in due course.The Company has a track record of significant, open and increasingly detailed disclosure to the market, as monitored and reviewed by its entirely independent disclosure committee.NMC remains a growth company, with a solid balance sheet generating strong levels of cash as demonstrated by yesterday's buyback of $90 million of its Convertible Bonds due 2025, which has been repaid through existing cash balance. This prepayment is in addition to the regular amortization of long-term loans during 2019. NMC also reiterated its leverage guidance for 2019.NMC reaffirms its broader trading and operational guidance for the business for both 2019 and 2020 as disclosed at its recent Capital Markets Day held on 21 October 2019.Additionally, in a separate announcement this morning, the Company announced that it has put in the place the formal mechanism through which it can now begin to execute the $200 million share buyback programme that NMC's shareholders approved on 5 December 2019.
17/12/2019
11:28
biteherbutt: This is what NMC said in August 8 August 2019 NMC Health plc (the "Company" or "NMC") Statement re. share price movement NMC Health plc (LSE: NMC), the leading private healthcare operator in the Gulf Cooperation Council (GCC) with international services across 19 countries, notes the recent share price weakness and confirms that it expects to report that, after a good performance in the first half of 2019, trading in the business remains in line with management expectations on all key metrics including revenue, EBITDA, net income, leverage, cash flow conversion and working capital. Full year guidance remains as previously stated.
27/8/2019
12:36
mohdusman44: @Alexak1, keeping a close watch at what price the company will be doing the buy backs. Looks like this time, NMC share price will beat TP recommended by the Analysts. As NMC's CEO rightly commented in its HY results announcement, there is big disconnect between fundamentals and valuation which is bound to get corrected soon. The stock should be somewhere around gbp 2500, by the time the management is done with its road shows covering multi-continents.
14/8/2019
16:22
nsee700: lets say this price is being dictated by a SWF like ADIA or SIA then it should still be bought to the regulators attention for manipulation! Agreed some of the slip in share price has to do with market sentiment such as trade wars with US and China, Germany, US, UK slipping into the negative for the first time, general slowdown in the Middle East and the knock on effect of that on NMC share price. It still does not explain the drop to 4,000 to 1,800 in a matter of less than a year
10/8/2019
14:38
alexka1: Here is the CITI note published 2 days ago... as i said over 20% if short - this is the time to buy, its so crowded as a trade on no news. just ppl getting on a trade without reasons following the few big HFs and recent price slumps. NMC Health (NMC.L) Alert: Stock down >10% on no news, our thoughts... The NMC share price is 10-15% lower in afternoon trading, and we see no company-specific or industry news flow. We struggle to explain the move based on fundamentals but offer thoughts on what might be driving the shares weaker, however unjustified we think the move is: – Yesterday, NMC’s shares fell ~7% on no news flow as well: We believe that some investors might have drawn negative conclusions regarding NMC from a tweet by Muddy Waters Research about a new publication released on 7 August. The stock in this publication turned out to be Burford Capital Ltd (BURF.L, not rated), which today is trading ~50% lower. The knock-on effects of this severe move for Burford could be impacting NMC’s share price (on risk aversion). – The influence of the shorts could be accentuating these moves: >20% of NMC’s float is shorted currently, and a large portion of the short positions are at momentum funds, which could be compounding the price action. With Monday’s positive development of the partial removal of pledged stock by insiders, some active shorts may see time as running out for the forced selling to be triggered related to pledged stock (see NMC Health - Partial pledge removal). Total removal of the pledge would dent the bear case, in our view. Active shorts might be opportunistically aggressive in their selling now. – Lack of buyers to step in is concerning, to us: We are surprised that NMC bulls didn’t see good enough value or have high enough conviction in the stock to apprehend a slide of this quantum. – We like the fundamental story and continue to rate NMC a Buy: Modest EPS cut, big TP cut to reflect new reality. Retain Buy. Citi Research Equities Health Care Facilities CEEMEA │ United Arab Emirates
08/10/2018
07:26
smartinvest1: Nmc share price should go up as VIX is going up.
Nmc Health share price data is direct from the London Stock Exchange
Your Recent History
LSE
NMC
Nmc Health
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200126 21:02:29